Affiliation:
1. Department of Urology, Faculty of Medicine, Kagawa University, Kagawa 761-0793, Japan
Abstract
Active surveillance has emerged as a promising approach for managing low-risk and favorable intermediate-risk prostate cancer (PC), with the aim of minimizing overtreatment and maintaining the quality of life. However, concerns remain about identifying “aggressive prostate cancer” within the active surveillance cohort, which refers to cancers with a higher potential for progression. Previous studies are predictors of aggressive PC during active surveillance. To address this, a personalized risk-based follow-up approach that integrates clinical data, biomarkers, and genetic factors using risk calculators was proposed. This approach enables an efficient risk assessment and the early detection of disease progression, minimizes unnecessary interventions, and improves patient management and outcomes. As active surveillance indications expand, the importance of identifying aggressive PC through a personalized risk-based follow-up is expected to increase.
Reference85 articles.
1. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021
2. He, W., Goodkind, D., and Kowal, P. (2023, June 16). An Aging World, Available online: https://www.census.gov/content/dam/Census/library/publications/2016/demo/p95-16-1.pdf.
3. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer;Catalona;N. Engl. J. Med.,1991
4. Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: Additional diagnoses and avoided deaths;Zappa;Ann. Oncol.,2012
5. Long-term functional outcomes after treatment for localized prostate cancer;Resnick;N. Engl. J. Med.,2013
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献